Company / Working Capital per Share
CG Oncology, Inc. Working Capital per Share History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$9.43
FY2025
5-year range
$9.43 / $41.53
FY2023-FY2025
Trend
-19.6%
vs FY2024
Sector context
#51 of 210
Health Care
What the data says
CG Oncology, Inc.'s working capital per share of $9.43 is higher than 76% of companies in the Health Care sector (FY2025). Declined from $41.53 to $9.43 over the past 2 years.
Based on SEC 10-K filings.
9.43 in FY2025. Top quartile in the Health Care sector.
Declined from $41.53 to $9.43 over the past 2 years.
Health Care sector context is included.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 24% in Health CareTop 24% of 210This company $9.43 Sector average $146.71
▼
-93.6% below sector average
Key checks
Key Insights
- In FY2025, working capital per share decreased 19.6% year-over-year.
- Ranks #51 out of 210 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 8.02 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $9.43 | -19.6% |
| FY2024 | $11.73 | -71.8% |
| FY2023 | $41.53 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026